Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02985866 · ClinicalTrials.gov registry record · NA
The International Diabetes Closed Loop (iDCL) Trial: Protocol 1
A NA study of Type 1 Diabetes Mellitus, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 127
- Enrollment target
- 7
- Study locations
NCT02985866: Completed NA study of Type 1 Diabetes Mellitus, sponsored by University of Virginia.
NCT02985866 is a NA study of Type 1 Diabetes Mellitus that has completed, run by University of Virginia. The registered enrollment target is 127 participants, below the 171-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target (26% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02985866, a NA study of Type 1 Diabetes Mellitus, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 127 participants
- Enrollment target
- 7
- Study locations
Study Summary
The objective of the study is to assess the efficacy and safety of home use of a Control-to-Range (CTR) closed-loop (CL) system.
Primary Outcome
CGM-measured % time below 70 mg/dL - 1st co-primary outcome (superiority)
Conditions Studied
Interventions
- DEVICE Artificial Pancreas
- OTHER Sensor Augmented Therapy
Study Locations (7)
California
- William Sansum Diabetes Center - Santa Barbara
- Stanford University - Stanford
Colorado
- Barbara Davis Center, University of Colorado - Aurora
Massachusetts
- Harvard University (Joslin Diabetes Center) - Boston
Minnesota
- Mayo Clinic - Rochester
New York
- Icahn School of Medicine at Mount Sinai - New York
Virginia
- University of Virginia Center for Diabetes Technology - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2017-10-27 |
| Est. Completion | 2018-09-04 |
| Phase | NA |
What the finished NCT02985866 record still lists
NCT02985866 is an interventional study that assigns participants to a tested intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap, below the 171-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Artificial Pancreas is the first listed.
NCT02985866 lists 7 locations in 6 states (California, Colorado, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT02985866 about?
NCT02985866 is a clinical study titled "The International Diabetes Closed Loop (iDCL) Trial: Protocol 1". The objective of the study is to assess the efficacy and safety of home use of a Control-to-Range (CTR) closed-loop (CL) system.
What is the current status of trial NCT02985866?
This trial is currently completed. It is a NA study. The enrollment target is 127 participants. The study started on 2017-10-27. Estimated completion is 2018-09-04.
What conditions does trial NCT02985866 study?
This clinical trial studies the following conditions: Type 1 Diabetes Mellitus.
What interventions are being tested in trial NCT02985866?
The interventions under investigation include: Artificial Pancreas (DEVICE), Sensor Augmented Therapy (OTHER).
Who is sponsoring clinical trial NCT02985866?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02985866 being conducted?
This trial has 7 study locations across California, Colorado, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02985866's enrollment target sits among peer trials
127 25th of 112 higher than 88 of 112 other Type 1 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
RECRUITING · NA
-
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
RECRUITING · NA
-
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
RECRUITING · NA
-
PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI